acamprosate has been researched along with Acute Confusional Senile Dementia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertrand, V; Boucard, A; Callizot, N; Cholet, N; Chumakov, I; Cohen, D; Foucquier, J; Graudens, E; Guedj, M; Hajj, R; Maurice, T; Milet, A; Nabirotchkin, S; Pereira, Y; Scart-Grès, C; Steinschneider, R; Toulorge, D; Traoré, S; Vial, E | 1 |
| Borges, S; Flockhart, D; Preskorn, SH | 1 |
1 review(s) available for acamprosate and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Clinically relevant pharmacology of neuropsychiatric drugs approved over the last three years: part I.
Topics: Acamprosate; Alcohol Deterrents; Alcoholism; Alzheimer Disease; Brain; Dopamine Agents; Humans; Memantine; Mental Disorders; Psychotropic Drugs; Taurine | 2006 |
1 other study(ies) available for acamprosate and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Combining two repurposed drugs as a promising approach for Alzheimer's disease therapy.
Topics: Acamprosate; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apoptosis; Baclofen; Cells, Cultured; Disease Models, Animal; Drug Repositioning; Drug Synergism; Female; Humans; Male; Mice; Mice, Transgenic; Neurons; Neuroprotective Agents; Peptide Fragments; Rats; Rats, Wistar; Signal Transduction; Taurine | 2015 |